Recce Pharmaceuticals Ltd. (ASX:RCE)
Share Price and News
Recce Pharmaceuticals Ltd (ASX: RCE) is an Australia-based biotech company which is pioneering the development along with the commercialisation of a new kind of synthetic antibiotics. RECCE 327, Recce’s patented product, has been developed for the treatment of sepsis and blood infections. It was founded in 2007 and has a manufacturing facility in Australia.